- In May 2024, Asahi Kasei Medical, a bioprocess business, launched a new assembly plant for Planova virus removal filters. A new assembly plant for Planova was completed in 2024. This highlights continuous innovation in filtration technologies critical for biopharmaceutical safety
- In December 2024, Advances in peptide purification techniques for mass spectrometry-based proteomics have been reported, including the development of high-recovery desalting tip columns. These innovations are designed to minimize peptide loss during the desalting step, crucial for improving sensitivity and coverage in proteomics research
- In November 2023, Cytiva launched new ÄKTA go desalting and buffer exchange system. This system is designed to automate desalting and buffer exchange workflows, making them faster, more efficient, and more reproducible, addressing the growing need for automation in bioprocessing
- In October 2023, Cytiva, a part of Danaher, expanded its footprint in India with the launch of a biologics manufacturing hub in Pune.This 33,000 sq ft facility will manufacture bioprocessing equipment, including tangential flow, virus filtration, and inactivation systems, supporting the growing biopharmaceutical production in the region
- In February 2022, Sartorius Stedim Biotech, a subgroup of Sartorius, finalized the acquisition of Novasep's chromatography division.This strategic move expanded Sartorius's chromatography offerings and strengthened its position in the bioprocessing industry, indicating consolidation and strengthening of key players
